Bio-Rad director RSUs vest into 117 shares
Bio-Rad director Allison Schwartz had RSUs vest into 117 Class A shares, with 43 shares withheld or delivered to cover exercise price or tax obligations.
Rhea-AI Filing Summary
BIO-RAD LABORATORIES, INC. (BIO) reported that director Allison Schwartz had restricted stock units vest and convert into Bio-Rad Class A common stock on September 1, 2026. A total of 117 shares of Class A common stock were acquired upon vesting of restricted stock units granted in 2022 and 2023.
The vesting reflects the conversion of 42 restricted stock units from a 2022 grant and 75 restricted stock units from a 2023 grant, each unit representing a contingent right to one Class A share. Of the vested shares, 43 shares were delivered or withheld to cover the exercise price or tax liability at $380.96 per share. No Rule 10b5-1 trading plan is reported for these transactions.
Positive
- None.
Negative
- None.
Insider Trade Summary
117 shares exercised/converted
Exercise
4 txns
Insider
Allison Schwartz
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units F2, F3 | 42 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units F2, F4 | 75 | $0.00 | $0.00 |
| Exercise | Bio-Rad A Common Stock F1 | 117 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Bio-Rad A Common Stock | 43 | $380.96 | $16K |
Holdings After Transaction:
Restricted Stock Units — 75 contracts (Direct);
Bio-Rad A Common Stock — 1,530 shares (Direct)
Footnotes (4)
- F1. Shares of Class A common stock acquired on the vesting of restricted stock units.
- F2. Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
- F3. On September 1, 2022, the reporting person was granted 167 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
- F4. On September 1, 2023, the reporting person was granted 298 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
Key Figures
Restricted stock units converted (2022 grant portion): 42 units
Restricted stock units converted (2023 grant portion): 75 units
Shares of Bio-Rad Class A common stock acquired: 117 shares
+4 more
7 metrics
Restricted stock units converted (2022 grant portion)
42 units
Units converting into Bio-Rad Class A common stock on September 1, 2026
Restricted stock units converted (2023 grant portion)
75 units
Units converting into Bio-Rad Class A common stock on September 1, 2026
Shares of Bio-Rad Class A common stock acquired
117 shares
Shares received upon vesting of restricted stock units on September 1, 2026
Shares delivered or withheld for exercise price or tax liability
43 shares
Shares used to satisfy exercise price or tax liability related to vesting
Share price used for tax or exercise settlement
$380.96 per share
Price applied to the 43 Bio-Rad Class A shares delivered or withheld
2022 restricted stock unit grant size
167 units
Granted September 1, 2022, vesting in four equal annual installments
2023 restricted stock unit grant size
298 units
Granted September 1, 2023, vesting in four equal annual installments
Key Terms
Restricted Stock Units, contingent right, Class A common stock, Payment of exercise price or tax liability
4 terms
Restricted Stock Units financial
"Shares of Class A common stock acquired on the vesting of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share"
Class A common stock financial
"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
Payment of exercise price or tax liability financial
"Payment of exercise price or tax liability by delivering or withholding securities"
FAQ
What did Bio-Rad Laboratories (BIO) disclose about Allison Schwartz’s recent equity transactions?
Bio-Rad disclosed that director Allison Schwartz had restricted stock units vest on September 1, 2026, converting into 117 shares of Bio-Rad Class A common stock, with 43 shares delivered or withheld to cover exercise price or tax liability.
How many Bio-Rad (BIO) restricted stock units vested for Allison Schwartz?
A total of 117 restricted stock units vested and converted into an equal number of Bio-Rad Class A common shares: 42 units from a 2022 grant and 75 units from a 2023 grant, each unit representing one share of Class A common stock.
Were Allison Schwartz’s Bio-Rad (BIO) transactions under a Rule 10b5-1 trading plan?
No. The Form 4 indicates that the Rule 10b5-1 checkbox is not marked, and the footnotes do not describe any Rule 10b5-1 trading plan, so these transactions are not reported as being made under such a plan.
What grants did the vested Bio-Rad (BIO) restricted stock units come from?
The vested units came from two grants: 167 restricted stock units granted on September 1, 2022, vesting over four annual installments, and 298 restricted stock units granted on September 1, 2023, also vesting in four equal annual installments beginning one year after the grant date.
Does the Bio-Rad (BIO) Form 4 show any open-market buy or sell by Allison Schwartz?
No. The reported transactions are the vesting and conversion of restricted stock units into Class A common stock and the delivery or withholding of 43 shares to cover exercise price or tax liability, with no open-market purchases or sales reported.
AI-generated analysis. How Rhea-AI works. Not financial advice.
